Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder? | Neurology Neuroimmunology & Neuroinflammation
Clinical and immunological differences between MOG associated disease and anti AQP4 antibody-positive neuromyelitis optica spectrum disorders: Blood–brain barrier breakdown and peripheral plasmablasts - Multiple Sclerosis and Related Disorders
Frontiers | Serum and Cerebrospinal Fluid Biomarkers in Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Associated Disease
Metabolites | Free Full-Text | Metabolomic Profiling in Neuromyelitis Optica Spectrum Disorder Biomarker Discovery | HTML
The spectrum of MOG autoantibody-associated demyelinating diseases | Nature Reviews Neurology